PIC Therapeutics, Inc. — Form D
PIC Therapeutics, Inc. of Natick, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-15. The offering totals $11.5M, of which $11.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-04-15
- Form: D
- Accession: 0001808352-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.5M
- Amount sold: $11.5M
- Investors: 36
- Date of first sale: 2020-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-364998
Issuer
- Name: PIC Therapeutics, Inc.
- CIK: 0001808352
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 22 Strathmore Road, Natick, MA, 01760
- Phone: 617-528-8715
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Sun Altbach | Director | Boston, MA |
| Dr. Richard E Peters | Director | Boston, MA |
| Sun Altbach | Executive Officer | Boston, MA |
| Gerry E Brunk | Director | Toronto, A6 |
| Tal E Zaks, MD, PhD | Director | New York, NY |
| Belinda E Termeer | Director | Natick, MA |
| Dr. Alan E Walts | Director | Natick, MA |
| Dr. Katherine S Bowdish | Director | Natick, MA |
| Dr. Katherine S Bowdish | Executive Officer | Natick, MA |
| Dr. Gerhard E Wagner | Director | Natick, MA |
Other filings by this issuer (2)
More